Regional Monitoring EECA
by ECUO PLWH
Showing 1-7 of 7 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.39217098503041.76569952380111.252015Not specifiedNot specifiedNot specified
2Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.733318903022631386VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
3Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.26241803036208067490162016YesYesNot specified
4Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps5.61473030168.441168.442015Not specifiedNot specifiedNot specified
5Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine400mg caps1.40113008303042.03433611822462.882015Not specifiedNot specifiedNot specified
6GeorgiaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.666718003020601200partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
7Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps6.496-30194.88--National Health Service (NHC)2016Not specifiedNot specifiedNot specified